К основному контенту

Accupril

Accupril

     * Generic Name: quinapril hydrochloride
     * Brand Name: Accupril


     * What is quinapril (Accupril)?
     * What are the possible side effects of quinapril (Accupril)?
     * What is the most important information I should know about
       quinapril (Accupril)?
     * What should I discuss with my healthcare provider before taking
       quinapril (Accupril)?
     * How should I take quinapril (Accupril)?
     * What happens if I miss a dose (Accupril)?
     * What happens if I overdose (Accupril)?
     * What should I avoid while taking quinapril (Accupril)?
     * What other drugs will affect quinapril (Accupril)?
     * Where can I get more information (Accupril)?

What is quinapril (Accupril)?

   Quinapril is an ACE inhibitor. ACE stands for angiotensin
   converting enzyme.

   Quinapril is used to treat high blood pressure (hypertension)
   and heart failure.

   Quinapril may also be used for purposes not listed in this medication
   guide.

What are the possible side effects of quinapril (Accupril)?

   Get emergency medical help if you have signs of an allergic reaction:
   hives; severe stomach pain; difficulty breathing; swelling of your
   face, lips, tongue, or throat.

   Call your doctor at once if you have:
     * a light-headed feeling, like you might pass out;
     * fast or pounding heartbeats, fluttering in your chest;
     * little or no urination;
     * pain or burning when you urinate;
     * jaundice (yellowing of the skin or eyes);
     * numbness, tingling, or burning pain in your hands or feet;
     * fever, chills, cold or flu symptoms;
     * high potassium--nausea, slow or unusual heart rate, weakness,
       loss of movement; or
     * low sodium--headache, confusion, slurred speech, severe
       weakness, vomiting, loss of coordination, feeling unsteady.

   Common side effects may include:
     * headache;
     * cough; or
     * dizziness, tired feeling.

   This is not a complete list of side effects and others may occur. Call
   your doctor for medical advice about side effects. You may report side
   effects to FDA at 1-800-FDA-1088.

What is the most important information I should know about quinapril
(Accupril)?

   Do not use if you are pregnant. If you become pregnant, stop taking
   this medicine and tell your doctor right away.

   You should not use quinapril if you have ever had angioedema. Do
   not take quinapril within 36 hours before or after taking medicine that
   contains sacubatril (such as Entresto).

   If you have diabetes, do not use quinapril together with any medication
   that contains aliskiren (such as Tekturna or Tekamlo).

   Accupril Patient Information including How Should I Take
   High Blood Pressure: Learn About Hypertension

   High Blood Pressure Slideshow Pictures
   RxList

   Take the Salt Quiz!
   Lowering Blood Pressure:Exercise Tips for Getting Started

   Lowering Blood Pressure Exercise Tips Pictures

What should I discuss with my healthcare provider before taking quinapril
(Accupril)?

   You should not use quinapril if you are allergic to it, or if:
     * you have a history of angioedema;
     * you recently took a heart medicine called sacubatril; or
     * if you are allergic to any other ACE inhibitor, such as
       benazepril, captopril, enalapril, fosinopril,
       lisinopril, moexipril, perindopril, ramipril, or
       trandolapril.

   Do not take quinapril within 36 hours before or after taking medicine
   that contains sacubatril (such as Entresto).

   If you have diabetes, do not use quinapril together with any medication
   that contains aliskiren (such as Tekturna or Tekamlo).

   You may also need to avoid taking quinapril with aliskiren if you have
   kidney disease.

   To make sure quinapril is safe for you, tell your doctor if you have
   ever had:
     * kidney disease (or if you are on dialysis);
     * liver disease;
     * a connective tissue disease such as Marfan syndrome,
       Sjogren's syndrome, lupus, scleroderma, or
       rheumatoid arthritis;
     * heart disease or congestive heart failure (unless you are
       taking quinapril for this condition); or
     * if you are on a low-salt diet.

   Do not use if you are pregnant. If you become pregnant, stop taking
   this medicine and tell your doctor right away. Quinapril can cause
   injury or death to the unborn baby if you take the medicine during your
   second or third trimester.

   Quinapril can pass into breast milk and may harm a nursing baby. Tell
   your doctor if you are breast-feeding a baby.

How should I take quinapril (Accupril)?

   Follow all directions on your prescription label. Your doctor may
   occasionally change your dose. Do not take this medicine in larger or
   smaller amounts or for longer than recommended.

   Your blood pressure will need to be checked often. Your kidney or liver
   function may also need to be tested.

   Call your doctor if you have ongoing vomiting or diarrhea, or if you
   are sweating more than usual. You can easily become dehydrated while
   taking quinapril. This can lead to very low blood pressure,
   electrolyte disorders, or kidney failure.

   If you need surgery, tell the surgeon ahead of time that you are
   using quinapril. You may need to stop using the medicine for a short
   time.

   If you are being treated for high blood pressure, keep using this
   medicine even if you feel well. High blood pressure often has no
   symptoms. You may need to use blood pressure medicine for the rest of
   your life.

   Store at room temperature away from moisture, heat, and light.

   Accupril Patient Information including If I Miss a Dose
   High Blood Pressure: Learn About Hypertension

   High Blood Pressure Slideshow Pictures
   RxList

   Take the Salt Quiz!
   Lowering Blood Pressure:Exercise Tips for Getting Started

   Lowering Blood Pressure Exercise Tips Pictures

What happens if I miss a dose (Accupril)?

   Take the missed dose as soon as you remember. Skip the missed dose if
   it is almost time for your next scheduled dose. Do not take extra
   medicine to make up the missed dose.

What happens if I overdose (Accupril)?

   Seek emergency medical attention or call the Poison Help line at
   1-800-222-1222.

What should I avoid while taking quinapril (Accupril)?

   Do not use salt substitutes or potassium supplements while taking
   quinapril, unless your doctor has told you to.

   Drinking alcohol can further lower your blood pressure and may increase
   certain side effects of quinapril.

   Avoid getting up too fast from a sitting or lying position, or you may
   feel dizzy. Get up slowly and steady yourself to prevent a fall.

What other drugs will affect quinapril (Accupril)?

   Tell your doctor about all your current medicines and any you start or
   stop using, especially:
     * lithium;
     * a diuretic or "water pill";
     * gold injections to treat arthritis; or
     * NSAIDs (nonsteroidal anti-inflammatory drugs)--aspirin, ibuprofen
       (Advil, Motrin), naproxen (Aleve), celecoxib,
       diclofenac, indomethacin, meloxicam, and others.

   This list is not complete. Other drugs may interact with quinapril,
   including prescription and over-the-counter medicines, vitamins, and
   herbal products. Not all possible interactions are listed in this
   medication guide.

Where can I get more information (Accupril)?

   Your pharmacist can provide more information about quinapril.
     __________________________________________________________________


Комментарии

Популярные сообщения из этого блога

A healthy diet may trigger a better response to a certain kind of melanoma treatment. How?

New research suggests that a diet that's full of fiber appears to lead to more diverse intestinal bacteria (microbiome). In turn, a thriving gut microbiome is linked to a stronger response to an immune therapy for the aggressive skin cancer. "We found that patients eating a high-fiber diet at the start of therapy were about five times more likely to respond to the anti-PD-1 immunotherapy," said study author Christine Spencer. She's a research scientist with the Parker Institute for Cancer Immunotherapy in San Francisco. Anti-PD-1 immunotherapy helps the immune system recognize cancer cells as dangerous cells that need to be destroyed, according to the American Cancer Society (ACS). The cancer drugs Keytruda and Opdivo are examples of this type of immunotherapy. Melanoma is a type of skin cancer. It only accounts for about 1 percent of all skin cancers, but is responsible for most skin cancer deaths, the ACS says. Several recent studies have suggested that a ...

American Heart Association News

On Feb. 1, 1961, twins Debbie and Donna Horst arrived at the White House to fanfare. The 6-year-olds, decked out in fancy dresses and satin sashes, found themselves surrounded by a pressing crowd and a sea of blinding flashbulbs as they made their way to see Jacqueline Kennedy. The girls -- both born with holes in their aortas -- were meeting with the first lady to kick off a national campaign to raise awareness about congenital heart defects. "There were hundreds of reporters because this was Jacqueline Kennedy' first public act as first lady," Debbie said. She recalls being startled when the reporters asked Mrs. Kennedy if they could move in closer. "It was frightening because they all jumped at us at once." The Pennsylvania twins, just a few weeks from turning 7, were among the first "Heart Fund Sweethearts" in the campaign to raise money as well as awareness. The month before, they'd met up with Micki and Patricia Gane, also of Pennsylvania...

Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose

Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch, Twirla PRINCETON, N.J., May 17, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced it has resubmitted to the U.S. Food and Drug Administration (FDA) the NDA for its lead product candidate, Twirla®, an investigational low-dose combined hormonal contraceptive patch (AG200-15).  Agile resubmitted the NDA in response to a December 2017 Complete Response Letter (CRL) from the FDA, which identified deficiencies relating to (i) quality control adhesion test methods for the Twirla manufacturing process, (ii) observations identified during an inspection of a facility of our third-party manufacturer for the Twirla NDA that must be resolved, and (iii) questions on the in vivo adhesion properties of Twirla and their potential relationship to the SECURE clinical trial results. The resubmitted NDA includes the results from a...